In acute myeloid leukemia (AML), inhibition of phosphoseryl-tRNA kinase (PSTK), a critical enzyme in selenoprotein biosynthesis, has been shown to selectively impair AML growth and eradicate chemoresistant leukemic stem cells while sparing normal hematopoietic cells [27]. This evidence concerns the gene PSTK and acute myeloid leukemia.